Kidney versus liver specification of SLC and ABC drug transporters, tight junction molecules, and biomarkers

Drug Metabolism and Disposition

Volumn 44, Issue 7, 2016, Pages 1050-1060

  Martovetsky, Gleb ^a   Bush, Kevin T ^a   Nigam, Sanjay K ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ALBUMIN; APOLIPOPROTEIN; BIOLOGICAL MARKER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CLAUDIN 6; EXCITATORY AMINO ACID TRANSPORTER 4; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; OCCLUDIN; ORGANIC ANION TRANSPORTER 1; PROTEIN ZO1; PROTEIN ZO2; SODIUM PHOSPHATE COTRANSPORTER 2A; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSFERRIN; URATE TRANSPORTER; ORGANIC CATION TRANSPORTER; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TRANSDIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ECTOPIC EXPRESSION; EMBRYO; FIBROBLAST; GENE EXPRESSION; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TIGHT JUNCTION; UPREGULATION; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINEAGE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; KIDNEY PROXIMAL TUBULE; LIVER; LIVER CELL; METABOLISM; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOMARKERS; CELL DIFFERENTIATION; CELL LINEAGE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HEPATOCYTES; HUMANS; KIDNEY TUBULES, PROXIMAL; LIVER; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; ORGANIC CATION TRANSPORT PROTEINS; RATS; TIGHT JUNCTION PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84975144900     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.115.068254     Document Type: Article

References (37)

1. Ahn SY and Nigam SK (2009) Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol 76:481-490.
2. Balkovetz DF (2009) Tight junction claudins and the kidney in sickness and in health. Biochim Biophys Acta 1788:858-863.
3. Denker BM and Nigam SK (1998) Molecular structure and assembly of the tight junction. Am J Physiol 274:F1-F9.
4. Du Y, Wang J, Jia J, Song N, Xiang C, Xu J, Hou Z, Su X, Liu B, and Jiang T, et al. (2014) Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell 14:394-403.
5. Eraly SA, Vallon V, Vaughn DA, Gangoiti JA, Richter K, Nagle M, Monte JC, Rieg T, Truong DM, and Long JM, et al. (2006) Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem 281:5072-5083.
6. Graf T and Enver T (2009) Forcing cells to change lineages. Nature 462:587-594.
7. Harding J and Mirochnitchenko O (2014) Preclinical studies for induced pluripotent stem cell-based therapeutics. J Biol Chem 289:4585-4593.
8. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576-589.
9. Hou J (2014) The kidney tight junction (Review). Review Int J Mol Med 34:1451-1457.
10. Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, and Hui L (2011) Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475:386-389.
11. Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, Cen J, Chen X, Liu C, and Hu Y, et al. (2014) Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14:370-384.
12. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, and Kauffman RE (2003) Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157-1167.
13. Lee DB, Huang E, and Ward HJ (2006) Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290:F20-F34.
14. Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR, and Nigam SK (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471-6478.
15. Lu X and Zhao T (2013) Clinical therapy using iPSCs: hopes and challenges. Genomics Proteomics Bioinformatics 11:294-298.
16. Martovetsky G and Nigam SK (2014) Cellular and developmental strategies aimed at kidney tissue engineering. Nephron, Exp Nephrol 126:101.
17. Martovetsky G, Tee JB, and Nigam SK (2013) Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters. Mol Pharmacol 84:808-823.
18. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, and Meissner A (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454:49-55.
19. Morrissey KM, Wen CC, Johns SJ, Zhang L, Huang SM, and Giacomini KM (2012) The UCSF-FDA TransPortal: a public drug transporter database. Clin Pharmacol Ther 92:545-546.
20. Nagle MA, Truong DM, Dnyanmote AV, Ahn SY, Eraly SA, Wu W, and Nigam SK (2011) Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. J Biol Chem 286:243-251.
21. Narayanan K, Schumacher KM, Tasnim F, Kandasamy K, Schumacher A, Ni M, Gao S, Gopalan B, Zink D, and Ying JY (2013) Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int 83:593-603.
22. Nigam SK (2013) Concise review: can the intrinsic power of branching morphogenesis be used for engineering epithelial tissues and organs? Stem Cells Transl Med 2:993-1000.
23. Nigam SK (2015) What do drug transporters really do? Nat Rev Drug Discov 14:29-44.
24. Nigam SK, Bush KT, Martovetsky G, Ahn SY, Liu HC, Richard E, Bhatnagar V, and Wu W (2015a) The organic anion transporter (OAT) family: a systems biology perspective. Physiol Rev 95:83-123.
25. Nigam SK, Wu W, Bush KT, Hoenig MP, Blantz RC, and Bhatnagar V (2015b) Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters. Clin J Am Soc Nephrol 10:2039-2049.
26. Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, and Miura K (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523-533.
27. Sekiya S and Suzuki A (2011) Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475:390-393.
28. Simeonov KP and Uppal H (2014) Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS One 9:e100134.
29. Sindhu C, Samavarchi-Tehrani P, and Meissner A (2012) Transcription factor-mediated epigenetic reprogramming. J Biol Chem 287:30922-30931.
30. Torres AM, Dnyanmote AV, Bush KT, Wu W, and Nigam SK (2011) Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury. J Biol Chem 286:26391-26395.
31. Truong DM, Kaler G, Khandelwal A, Swaan PW, and Nigam SK (2008) Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem 283:8654-8663.
32. Wikoff WR, Nagle MA, Kouznetsova VL, Tsigelny IF, and Nigam SK (2011) Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res 10:2842-2851.
33. Wu W, Bush KT, Liu HC, Zhu C, Abagyan R, and Nigam SK (2015) Shared ligands between organic anion transporters (OAT1 and OAT6) and odorant receptors. Drug Metab Dispos 43:1855-1863.
34. Wu W, Dnyanmote AV, and Nigam SK (2011) Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol 79:795-805.
35. Yu B, He ZY, You P, Han QW, Xiang D, Chen F, Wang MJ, Liu CC, Lin XW, and Borjigin U, et al. (2013) Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell 13:328-340.
36. Zaret KS and Carroll JS (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25:2227-2241.
37. Zhu C, Nigam KB, Date RC, Bush KT, Springer SA, Saier MH, Jr, Wu W, and Nigam SK (2015) Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: Structure-function implications and analysis of sequence motifs. PLoS One 10:e0140569.